155 results
Page 4 of 8
8-K
uhn5hpgdc65ral0u8m
13 Oct 20
Other Events
5:04pm
8-K
EX-99.1
by8b7t iqgr0ium5olj
7 Oct 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
caci7ikxkksbzadaq
7 Aug 20
Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Update
7:23am
8-K
EX-99.1
j8kkz6fqbj sgd2s
17 Jul 20
DEXTENZA® Sets Billable Insert In-Market Sales Record in June and Company Announces Preliminary Second Quarter 2020 Net Product Revenue
7:34am
8-K
EX-99.1
pru4uyarpu7r113ka
16 Jul 20
Results of Operations and Financial Condition
9:17am
8-K
di4ilp3fwx9 pr
6 Jul 20
Other Events
8:15am
8-K
EX-1.1
sukt4gjn s325iqai
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
8-K
EX-99.1
di8q0j8
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
8-K
EX-99.2
jg46tp07t7xwjytcbw
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
424B5
cinf jdvgqh
20 May 20
Prospectus supplement for primary offering
4:27pm
424B5
6x03t1rnl
19 May 20
Prospectus supplement for primary offering
4:54pm
8-K
hxlgr
14 May 20
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-99.1
a9n ky79yt
8 May 20
Ocular Therapeutix™ Reports First Quarter 2020 Financial Results and Business Update
7:05am
8-K
EX-99.1
sozao mln
13 Apr 20
Ocular Therapeutix™ Provides Business Update and Response to COVID-19 Global Pandemic
8:05am